punctate


Also found in: Medical, Encyclopedia, Wikipedia.

punc·tate

 (pŭngk′tāt′) also punc·tat·ed (-tā′tĭd)
adj.
Having tiny spots, points, or depressions.

[From Latin pūnctum, prick mark, from neuter past participle of pungere, to prick; see punctuate.]

punc·ta′tion n.

punctate

(ˈpʌŋkteɪt) or

punctated

adj
(Biology) having or marked with minute spots, holes, or depressions
[C18: from New Latin punctātus, from Latin punctum a point]
puncˈtation n

punc•tate

(ˈpʌŋk teɪt)

also punc′tat•ed,



adj.
marked with points or dots; having minute spots or depressions.
[1750–60; < New Latin pūnctātus dotted = Latin pūnct(um) point, dot + -ātus -ate1]
punc•ta′tion, n.
Mentioned in ?
References in periodicals archive ?
EyeGate is in the clinic for two different patient populations: photorefractive keratectomy ('PRK') surgery to demonstrate corneal wound repair and punctate epitheliopathies ('PE'), which includes dry eye.
EyeGate is in the clinic for two different patient populations: photorefractive keratectomy ("PRK") surgery to demonstrate corneal wound repair and punctate epitheliopathies ("PE"), which includes dry eye.
(NASDAQ: EYEG) shares are trading higher after the company received FDA approval to initiate its follow-on pilot study for punctate epitheliopathies (PE).
EyeGate plans to file the Investigational Device Exemption for initiation of the study in Q2 of 2019 and to complete the study in Q3 of 2019 with the de novo being "filed soon thereafter." Additionally, the company said it will "continue with rapid clinical development for the second indication, punctate epitheliopathies." Stephen From, CEO of EyeGate, said, "We are pleased with the FDA's feedback and are excited to be in a position to file the de novo application subsequent to completing the PRK pivotal study.
Rostrum quite long, arcuate, widened to apex, densely punctate, with two longitudinal striae from antennal insertion to base, with apico-lateral denticulate on each side.
Our patient had cataract, ectropion, and punctate keratopathy.
A total of four symptoms (Itching, Discharge, Photophobia and Watering) and four signs (Conjunctival hyperemia, papillary hypertrophy, Horner Trantas spots and punctate keratitis) were analyzed.
Of the imaged eyes with clinical disease, the routine ophthalmologic examination findings, anterior segment photographs, and iVCM findings of 4 eyes with punctate epithelial keratitis, 4 eyes with deep corneal keratitis, and 4 eyes with subepithelial infiltration were evaluated.
In the clinical presentation of porokeratosis, there were five subtypes identified:[1] (a) Porokeratosis of Mibelli (PM), (b) disseminated superficial actinic porokeratosis, (c) porokeratosis palmaris et plantaris disseminate, (d) linear subtype, and (e) punctate type of porokeratosis.
This was associated with a patchy follicular conjunctivitis and punctate corneal erosions.